import { H2, H3, P, UL, LI, Callout, ResearchNote } from "@/components/blog/article-prose"
import type { BlogPost } from "@/lib/blog/types"

const meta = {
  slug: "bpc-157-research-guide",
  title: "BPC-157 Research Guide: What the Peer-Reviewed Literature Shows",
  description:
    "A research-focused overview of BPC-157, the synthetic 15-amino-acid pentadecapeptide derived from a protein found in gastric juice. Covers structure, mechanisms studied in animal models, and what published preclinical literature reports.",
  publishedAt: "2026-05-15",
  author: "PrimeHelix Labz Research Team",
  readMinutes: 9,
  tags: ["BPC-157", "tissue repair", "research overview"],
} as const

function Article() {
  return (
    <>
      <Callout>
        All content on this site is provided strictly for in-vitro and laboratory
        research purposes. PrimeHelix Labz does not provide medical, clinical, or
        dosing guidance. None of the compounds discussed are approved by the FDA for
        human use.
      </Callout>

      <P>
        BPC-157 is one of the most widely discussed research peptides in the
        regenerative-research literature. Short for &ldquo;Body Protection
        Compound&ndash;157,&rdquo; it is a synthetic 15&ndash;amino&ndash;acid
        pentadecapeptide originally isolated as a partial sequence of a larger
        protective protein found in human gastric juice. Researchers have studied
        the molecule extensively in animal models since the early 1990s, with most
        published work focused on tissue-injury models, gut-mucosa integrity,
        tendon and ligament repair, and vascular response.
      </P>

      <P>
        This guide summarizes what the published preclinical literature reports
        about BPC-157, how it is typically handled in laboratory settings, and
        what considerations a research buyer should think about when sourcing the
        peptide.
      </P>

      <H2>Structure and identity</H2>
      <P>
        BPC-157 has the amino-acid sequence
        Gly&ndash;Glu&ndash;Pro&ndash;Pro&ndash;Pro&ndash;Gly&ndash;Lys&ndash;Pro&ndash;Ala&ndash;Asp&ndash;Asp&ndash;Ala&ndash;Gly&ndash;Leu&ndash;Val.
        It has a molecular weight of approximately 1419.5 Da. Unlike many native
        signaling peptides, BPC-157 does not occur in nature in this exact form;
        it is a stable synthetic fragment selected for its experimental
        bioactivity in injury models.
      </P>
      <P>
        Two principal forms appear in the research-supply market: a free-acid
        form and an acetate-salt form. Both are typically supplied as a
        lyophilized (freeze-dried) white powder.
      </P>

      <H2>Mechanisms studied in published research</H2>
      <P>
        Mechanistic literature on BPC-157 is largely based on rodent models. The
        most frequently reported mechanisms include:
      </P>
      <UL>
        <LI>
          <strong>Angiogenic signaling.</strong> Published studies report increased
          expression of vascular endothelial growth factor receptor 2 (VEGFR2) and
          enhanced microvessel formation at sites of experimental injury.
        </LI>
        <LI>
          <strong>Nitric-oxide pathway interaction.</strong> Several papers describe
          modulation of the nitric oxide system in models of vascular and gastric
          injury.
        </LI>
        <LI>
          <strong>Growth-factor expression.</strong> Animal studies have reported
          upregulation of growth-hormone receptor expression in tendon fibroblasts
          and changes in collagen-related gene expression.
        </LI>
        <LI>
          <strong>Modulation of the dopaminergic and serotonergic systems.</strong>
          Behavioral-research papers report changes consistent with neuromodulatory
          activity, primarily in rat models.
        </LI>
      </UL>
      <ResearchNote>
        Mechanisms reported in rodent models do not necessarily translate to
        humans. To date there are no completed Phase II/III human trials of
        BPC-157 published in peer-reviewed journals.
      </ResearchNote>

      <H2>Common research-model applications</H2>
      <P>
        BPC-157 appears most often in published literature in the following
        experimental contexts:
      </P>
      <UL>
        <LI>Achilles-tendon transection and repair models in rats</LI>
        <LI>Medial-collateral-ligament injury models</LI>
        <LI>Gastric-ulcer and inflammatory-bowel models</LI>
        <LI>Skin-wound and burn-healing models</LI>
        <LI>Models of segmental bone defect</LI>
      </UL>

      <H2>Handling and stability in the lab</H2>
      <H3>Lyophilized form</H3>
      <P>
        BPC-157 in lyophilized powder form is generally considered stable for
        extended periods when stored sealed at &minus;20&deg;C, protected from
        light and moisture. Manufacturer Certificates of Analysis usually quote
        a recommended shelf life of 24&ndash;36 months from manufacture under
        these conditions.
      </P>
      <H3>Reconstituted form</H3>
      <P>
        Once reconstituted&mdash;commonly in bacteriostatic water for laboratory
        purposes&mdash;peptide stability decreases markedly. Most published
        reconstitution-stability work suggests using reconstituted material
        within a few weeks while refrigerated at 2&ndash;8&deg;C, though this
        depends on solvent, concentration, and ambient conditions. For a
        deeper treatment of storage variables, see our companion article on
        peptide storage.
      </P>

      <H2>What &ldquo;research grade&rdquo; should mean</H2>
      <P>
        When sourcing BPC-157 for laboratory work, three independent attributes
        matter:
      </P>
      <UL>
        <LI>
          <strong>Identity verification</strong> &mdash; usually by mass spectrometry,
          confirming the molecular weight matches the expected sequence.
        </LI>
        <LI>
          <strong>Purity verification</strong> &mdash; typically by HPLC, expressed as
          a percentage. For published preclinical work, &ge;98% is common.
        </LI>
        <LI>
          <strong>Lot-specific Certificate of Analysis (COA).</strong> A COA
          referencing the same lot number as the vial in hand is essential for
          reproducibility. If you have not seen one before, our guide to{" "}
          <a className="text-primary underline" href="/blog/how-to-read-peptide-coa">
            reading a peptide COA
          </a>{" "}
          walks through what each section means.
        </LI>
      </UL>

      <H2>Frequently encountered terms</H2>
      <UL>
        <LI>
          <strong>Pentadecapeptide</strong> &mdash; a peptide consisting of 15 amino
          acids.
        </LI>
        <LI>
          <strong>Lyophilized</strong> &mdash; freeze-dried; the standard storage
          form for synthetic peptides.
        </LI>
        <LI>
          <strong>Bacteriostatic water</strong> &mdash; sterile water containing
          0.9% benzyl alcohol; used in research settings to inhibit microbial
          growth in reconstituted material.
        </LI>
        <LI>
          <strong>HPLC</strong> &mdash; high-performance liquid chromatography; the
          industry-standard purity assay for peptides.
        </LI>
      </UL>

      <H2>Further reading</H2>
      <P>
        For comparisons with another tissue-repair peptide frequently studied
        alongside BPC-157, see our article on{" "}
        <a className="text-primary underline" href="/blog/bpc-157-vs-tb-500">
          BPC-157 vs TB-500
        </a>
        . For storage and reconstitution best practices, see{" "}
        <a className="text-primary underline" href="/blog/peptide-storage-guide">
          our peptide storage guide
        </a>
        .
      </P>

      <Callout>
        <strong>Reminder:</strong> The information above is a summary of preclinical
        research literature for laboratory and educational purposes. It is not a
        recommendation for human use, and PrimeHelix Labz products are not
        intended for human consumption.
      </Callout>
    </>
  )
}

const post: BlogPost = {
  ...meta,
  Component: Article,
}

export default post
